IDEAYA Elects Yujiro Hata as Board Chairman (IDYA)

IDEAYA Biosciences (NASDAQ: IDYA) Board of Directors elected Dr. Yujiro Hata as its new Chairman, effective June 17, 2026. This leadership change follows an internal decision by the precision medicine oncology company. Dr. Hata previously served as IDEAYA's President, Chief Executive Officer, and a board member. His election marks a transition in the company's board leadership structure.